Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Vascular Tumors and Angiosarcomas

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the research and clinical aspects of vascular tumors, particularly angiosarcoma and epithelioid hemangioendothelioma. It covers topics such as treatment outcomes, diagnostic markers, genetic alterations, risk factors, and therapeutic options for various types of vascular tumors. The cluster also explores the impact of radiation therapy on the development of angiosarcoma and the role of liver transplantation in managing hepatic angiosarcoma.

82
Works

How has Vascular Tumors and Angiosarcomas's publication output changed over time?

ScholarIQpublication output · 2006–2018

Output grew100% over the shown period — from 1 works in 2006 to 2 in 2018.

1
1
1
1
1
1
2
1
1
2
2006200720092010201120142015201620172018

What are the most-cited papers on Vascular Tumors and Angiosarcomas?

ScholarIQmost cited works
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Robert G. Maki, David R. D’Adamo, Mary Louise Keohan, Michael Saulle, Scott M. Schuetze, Samir D. Undevia, Michael B. Livingston, Matthew M. Cooney, Martee L. Hensley, Monica Mita, Chris H. Takimoto, Andrew S. Kraft, Anthony Elias, Bruce Brockstein, Nathalie E. Blachère, Mark Edgar, Lawrence H. Schwartz, Li-Xuan Qin, Cristina R. Antonescu, Gary K. Schwartz
Journal of Clinical Oncology. 2009575 CitationsOPEN ACCESS
Primary malignant hepatic epithelioid hemangioendothelioma
Arianeb Mehrabi, Arash Kashfi, Hamidreza Fonouni, Peter Schemmer, Bruno M. Schmied, Peter Hallscheidt, Peter Schirmacher, Jürgen Weitz, Helmut Friess, Markus W. Büchler, Jan Schmidt
Cancer. 2006483 Citations
Carcinogenicity bioassays of vinyl chloride
C Maltoni, Giuseppe Lefemine
Environmental Research. 1974206 Citations
FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma
Yin P. Hung, Christopher D.�M. Fletcher, Jason L. Hornick
S37879208. 2016177 Citations
Primary and secondary angiosarcoma of the breast: The Mayo Clinic experience
Jeffrey S. Scow, Carol Reynolds, Amy C. Degnim, Ivy A. Petersen, James W. Jakub, Judy C. Boughey
S13860802. 2010141 Citations

Where is Vascular Tumors and Angiosarcomas research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Vascular Tumors and Angiosarcomas is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
13%
Green
0%
Hybrid
7%
Bronze
13%
Closed
67%

Related on ScholarIQ

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paper
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Paper
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Paper
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Paper
Soft-Tissue Sarcomas in Adults
Paper
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Paper
470M+ articles · free account